Cargando…
Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease
BACKGROUND: Although prior reports have evaluated the clinical and cost impacts of cardiovascular magnetic resonance (CMR) for low-to-intermediate-risk patients with suspected significant coronary artery disease (CAD), the cost-effectiveness of CMR compared to relevant comparators remains poorly und...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734365/ https://www.ncbi.nlm.nih.gov/pubmed/34986851 http://dx.doi.org/10.1186/s12968-021-00833-1 |
_version_ | 1784628003127427072 |
---|---|
author | Pandya, Ankur Yu, Yuan-Jui Ge, Yin Nagel, Eike Kwong, Raymond Y. Bakar, Rafidah Abu Grizzard, John D. Merkler, Alexander E. Ntusi, Ntobeko Petersen, Steffen E. Rashedi, Nina Schwitter, Juerg Selvanayagam, Joseph B. White, James A. Carr, James Raman, Subha V. Simonetti, Orlando P. Bucciarelli-Ducci, Chiara Sierra-Galan, Lilia M. Ferrari, Victor A. Bhatia, Mona Kelle, Sebastian |
author_facet | Pandya, Ankur Yu, Yuan-Jui Ge, Yin Nagel, Eike Kwong, Raymond Y. Bakar, Rafidah Abu Grizzard, John D. Merkler, Alexander E. Ntusi, Ntobeko Petersen, Steffen E. Rashedi, Nina Schwitter, Juerg Selvanayagam, Joseph B. White, James A. Carr, James Raman, Subha V. Simonetti, Orlando P. Bucciarelli-Ducci, Chiara Sierra-Galan, Lilia M. Ferrari, Victor A. Bhatia, Mona Kelle, Sebastian |
author_sort | Pandya, Ankur |
collection | PubMed |
description | BACKGROUND: Although prior reports have evaluated the clinical and cost impacts of cardiovascular magnetic resonance (CMR) for low-to-intermediate-risk patients with suspected significant coronary artery disease (CAD), the cost-effectiveness of CMR compared to relevant comparators remains poorly understood. We aimed to summarize the cost-effectiveness literature on CMR for CAD and create a cost-effectiveness calculator, useable worldwide, to approximate the cost-per-quality-adjusted-life-year (QALY) of CMR and relevant comparators with context-specific patient-level and system-level inputs. METHODS: We searched the Tufts Cost-Effectiveness Analysis Registry and PubMed for cost-per-QALY or cost-per-life-year-saved studies of CMR to detect significant CAD. We also developed a linear regression meta-model (CMR Cost-Effectiveness Calculator) based on a larger CMR cost-effectiveness simulation model that can approximate CMR lifetime discount cost, QALY, and cost effectiveness compared to relevant comparators [such as single-photon emission computed tomography (SPECT), coronary computed tomography angiography (CCTA)] or invasive coronary angiography. RESULTS: CMR was cost-effective for evaluation of significant CAD (either health-improving and cost saving or having a cost-per-QALY or cost-per-life-year result lower than the cost-effectiveness threshold) versus its relevant comparator in 10 out of 15 studies, with 3 studies reporting uncertain cost effectiveness, and 2 studies showing CCTA was optimal. Our cost-effectiveness calculator showed that CCTA was not cost-effective in the US compared to CMR when the most recent publications on imaging performance were included in the model. CONCLUSIONS: Based on current world-wide evidence in the literature, CMR usually represents a cost-effective option compared to relevant comparators to assess for significant CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-021-00833-1. |
format | Online Article Text |
id | pubmed-8734365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87343652022-01-07 Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease Pandya, Ankur Yu, Yuan-Jui Ge, Yin Nagel, Eike Kwong, Raymond Y. Bakar, Rafidah Abu Grizzard, John D. Merkler, Alexander E. Ntusi, Ntobeko Petersen, Steffen E. Rashedi, Nina Schwitter, Juerg Selvanayagam, Joseph B. White, James A. Carr, James Raman, Subha V. Simonetti, Orlando P. Bucciarelli-Ducci, Chiara Sierra-Galan, Lilia M. Ferrari, Victor A. Bhatia, Mona Kelle, Sebastian J Cardiovasc Magn Reson Research BACKGROUND: Although prior reports have evaluated the clinical and cost impacts of cardiovascular magnetic resonance (CMR) for low-to-intermediate-risk patients with suspected significant coronary artery disease (CAD), the cost-effectiveness of CMR compared to relevant comparators remains poorly understood. We aimed to summarize the cost-effectiveness literature on CMR for CAD and create a cost-effectiveness calculator, useable worldwide, to approximate the cost-per-quality-adjusted-life-year (QALY) of CMR and relevant comparators with context-specific patient-level and system-level inputs. METHODS: We searched the Tufts Cost-Effectiveness Analysis Registry and PubMed for cost-per-QALY or cost-per-life-year-saved studies of CMR to detect significant CAD. We also developed a linear regression meta-model (CMR Cost-Effectiveness Calculator) based on a larger CMR cost-effectiveness simulation model that can approximate CMR lifetime discount cost, QALY, and cost effectiveness compared to relevant comparators [such as single-photon emission computed tomography (SPECT), coronary computed tomography angiography (CCTA)] or invasive coronary angiography. RESULTS: CMR was cost-effective for evaluation of significant CAD (either health-improving and cost saving or having a cost-per-QALY or cost-per-life-year result lower than the cost-effectiveness threshold) versus its relevant comparator in 10 out of 15 studies, with 3 studies reporting uncertain cost effectiveness, and 2 studies showing CCTA was optimal. Our cost-effectiveness calculator showed that CCTA was not cost-effective in the US compared to CMR when the most recent publications on imaging performance were included in the model. CONCLUSIONS: Based on current world-wide evidence in the literature, CMR usually represents a cost-effective option compared to relevant comparators to assess for significant CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-021-00833-1. BioMed Central 2022-01-06 /pmc/articles/PMC8734365/ /pubmed/34986851 http://dx.doi.org/10.1186/s12968-021-00833-1 Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Pandya, Ankur Yu, Yuan-Jui Ge, Yin Nagel, Eike Kwong, Raymond Y. Bakar, Rafidah Abu Grizzard, John D. Merkler, Alexander E. Ntusi, Ntobeko Petersen, Steffen E. Rashedi, Nina Schwitter, Juerg Selvanayagam, Joseph B. White, James A. Carr, James Raman, Subha V. Simonetti, Orlando P. Bucciarelli-Ducci, Chiara Sierra-Galan, Lilia M. Ferrari, Victor A. Bhatia, Mona Kelle, Sebastian Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease |
title | Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease |
title_full | Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease |
title_fullStr | Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease |
title_full_unstemmed | Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease |
title_short | Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease |
title_sort | evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734365/ https://www.ncbi.nlm.nih.gov/pubmed/34986851 http://dx.doi.org/10.1186/s12968-021-00833-1 |
work_keys_str_mv | AT pandyaankur evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT yuyuanjui evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT geyin evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT nageleike evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT kwongraymondy evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT bakarrafidahabu evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT grizzardjohnd evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT merkleralexandere evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT ntusintobeko evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT petersensteffene evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT rashedinina evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT schwitterjuerg evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT selvanayagamjosephb evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT whitejamesa evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT carrjames evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT ramansubhav evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT simonettiorlandop evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT bucciarelliduccichiara evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT sierragalanliliam evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT ferrarivictora evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT bhatiamona evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease AT kellesebastian evidencebasedcardiovascularmagneticresonancecosteffectivenesscalculatorforthedetectionofsignificantcoronaryarterydisease |